Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Roxadustat on Bone and Neuropsychiatric Aspects in End Stage Kidney Disease Patients on Hemodialysis

NCT06917950 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT06917950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06917950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Roxadustat on Bone and Neuropsychiatric Aspects in End Stage Kidney Disease Patients on Hemodialysis
Lead sponsor
Mansoura University
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 15, 2025
Completion date
November 1, 2025
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia in end stage renal disease, depression anxiety disorder, kidney failure,chronic